140 related articles for article (PubMed ID: 728893)
1. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice.
Bruley-Rosset M; Florentin I; Kiger N; Davigny M; Mathé G
Cancer Treat Rep; 1978 Nov; 62(11):1641-50. PubMed ID: 728893
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
3. Restoration of impaired immune functions of aged animals by chronic bestatin treatment.
Bruley-Rosset M; Florentin I; Kiger N; Schulz J; Mathé G
Immunology; 1979 Sep; 38(1):75-83. PubMed ID: 159863
[TBL] [Abstract][Full Text] [Related]
4. Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.
Kiger N; Bruley-Rosset M; Huchet R; Mathe G
Immunology; 1980 Nov; 41(3):687-94. PubMed ID: 6970164
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapy.
Mathé G; Florentin I; Olsson L; Bruley-Rosset M; Schulz J; Kiger N; Orbach-Arbouys S; Schwarzenberg L; Pouillart P; de Vassal F
Cancer Treat Rep; 1978 Nov; 62(11):1613-21. PubMed ID: 103616
[TBL] [Abstract][Full Text] [Related]
6. Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E-/-) mice.
Shibata Y; Ohata H; Yamashita M; Tsuji S; Bradfield JF; Nishiyama A; Henriksen RA; Myrvik QN
Transl Res; 2007 Feb; 149(2):62-9. PubMed ID: 17240316
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific immunomodulating effects of BCG vaccine on antibody-dependent cell-mediated cytotoxicity.
Koychev C; Guencheva G; Mihailova S; Engibarov A
Dev Biol Stand; 1986; 58 ( Pt A)():389-93. PubMed ID: 3297873
[TBL] [Abstract][Full Text] [Related]
9. Restorative effects of levamisole on cell-mediated immune responses following chemotherapy with aniline mustard in mice bearing ADJ-PC5 plasmacytoma.
Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW
Cancer Treat Rep; 1978 Nov; 62(11):1627-35. PubMed ID: 310338
[TBL] [Abstract][Full Text] [Related]
10. Effects of levamisole on normal and malignant murine lymphocytes.
Gordon WC; Prager MD
J Natl Cancer Inst; 1978 Aug; 61(2):415-21. PubMed ID: 277729
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
12. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
[TBL] [Abstract][Full Text] [Related]
13. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
Grimaldi GF; Moriearty PL; Hoff R
Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553
[TBL] [Abstract][Full Text] [Related]
14. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
Mellow L; Sabbadini E
Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
[TBL] [Abstract][Full Text] [Related]
15. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
Kato K; Yamamoto K
Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
[TBL] [Abstract][Full Text] [Related]
16. Relationship of Bacillus Calmette-Guérin-induced suppressor cells to hematopoietic precursor cells.
Bennett JA; Marsh JC
Cancer Res; 1980 Jan; 40(1):80-5. PubMed ID: 6444212
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene expression in a mouse model: the first instillations with viable bacillus Calmette-Guerin determine the succeeding Th1 response.
De Boer EC; Rooijakkers SJ; Schamhart DH; Kurth KH
J Urol; 2003 Nov; 170(5):2004-8. PubMed ID: 14532842
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of T-cell mediated immunity by levamisole.
Renoux G; Renoux M; Teller MN; McMahon S; Guillaumin JM
Clin Exp Immunol; 1976 Aug; 25(2):288-96. PubMed ID: 782749
[TBL] [Abstract][Full Text] [Related]
19. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
[TBL] [Abstract][Full Text] [Related]
20. Effects of age on respiratory tract immunity in guinea pigs.
Ganguly R; Waldman RH; Craig CP; Lockey RF
Allergol Immunopathol (Madr); 1986; 14(1):1-7. PubMed ID: 3515884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
